Review
Role and Relevance of PEPT2 in Drug Disposition, Dynamics, and Toxicity

https://doi.org/10.2133/dmpk.23.236Get rights and content

Summary:

Pept2 knockout mice are an important tool to evaluate the evolving role and relevance of this proton-coupled oligopeptide transporter beyond drug disposition, where the transporter also modulates the pharmacodynamic and toxicodynamic effects of drug substrates. Our in vivo studies with glycylsarcosine in Pept2 knockout mice have established “proof of concept” that PEPT2 can have a significant effect on dipeptide disposition. Subsequent studies with the aminocephalosporin antibiotic cefadroxil have shown relevance to pharmacology and infectious disease. Finally, studies with the endogenous peptidomimetic 5-aminolevulinic acid have demonstrated relevance to toxicology in the framework of porphyria- and lead-induced neurotoxicity. These studies have consistently demonstrated the dual action of PEPT2 with respect to its apical localization in choroid plexus epithelium and kidney in: 1) effluxing substrates from CSF into choroid plexus, thereby affecting regional pharmacokinetics in brain; and 2) reabsorbing substrates from renal tubular fluid into proximal tubules, thereby affecting systemic pharmacokinetics and exposure. Moreover, these studies have shown that the regional effect of PEPT2 in limiting substrate concentrations in the CSF is more dramatic than its effect in increasing systemic exposure. In the case of 5-aminolevulinic acid, such regional modulation of drug disposition translates directly into significant changes in neurotoxicity.

References (0)

Cited by (74)

  • Finding a cell-permeable compound to inhibit inflammatory cytokines: Uptake, biotransformation, and anti-cytokine activity of javamide-I/-II esters

    2022, Life Sciences
    Citation Excerpt :

    Briefly, Eclipse Plus C18 (4.6 × 150 mm, 5 μm; Agilent technologies, Santa Clara, CA, USA) was used as a stationary phase. A two-phase linear gradient condition was utilized as follows; buffer A (20 mM NaH2PO4, pH 4.3) for 0–2 min, a first linear change from buffer A to buffer B (40% acetonitrile) for 2–18 min, a second linear change from buffer B (40% acetonitrile) A to buffer B (60% acetonitrile) for 18–25 min and buffer B (60% acetonitrile) for 5 min at the flow rate of 1 ml/min [1–34]. An autosampler was used to inject the sample (10 μl) into the Agilent 1260 Infinity Quaternary LC system (Agilent technologies, Santa Clara, CA, USA), and a photo diode array detector (1260 DAD) (Agilent technologies, Santa Clara, CA, USA) was used to detect sample peaks.

View all citing articles on Scopus

This study was partially funded by NIH Grants R01 GM035498 (DES) and R01 NS034709 and P01 HL018575 (RFK). MAK was supported by the Pharmacological Sciences Training Program of the NIH Grant T32 GM007767.

View full text